Vladimir A. Tyurin

Vladimir A. Tyurin

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Vladimir A. Tyurin

Department of Environmental and Occupational Health and Center for Free Radical and Antioxidant Health, University of Pittsburgh (Y.Y.T., V.A.T., A.A.K., V.E.K.).

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2014 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
JAJose Pedro Friedmann Angeli
Jose Pedro Friedmann Angeli
MSManuela Schneider
Manuela Schneider
BPBettina Proneth
Bettina Proneth
YTYulia Y. Tyurina
Yulia Y. Tyurina
VTVladimir A. Tyurin
Vladimir A. Tyurin
MCMarcus Conrad
Marcus Conrad
Ferroptosis is a non-apoptotic form of cell death induced by small molecules in specific tumour types, and in engineered cells overexpressing oncogenic RAS. Yet, its relevance in non-transformed cells and tissues is unexplored and remains enigmatic. Here, we provide direct genetic evidence that the knockout of glutathione peroxidase 4 (Gpx4) causes cell death in a pathologically relevant form of ferroptosis. Using inducible Gpx4−/− mice, we elucidate an essential role for the glutathione/Gpx4 axis in preventing lipid-oxidation-induced acute renal failure and associated death. We furthermore systematically evaluated a library of small molecules for possible ferroptosis inhibitors, leading to the discovery of a potent spiroquinoxalinamine derivative called Liproxstatin-1, which is able to suppress ferroptosis in cells, in Gpx4−/− mice, and in a pre-clinical model of ischaemia/reperfusion-induced hepatic damage. In sum, we demonstrate that ferroptosis is a pervasive and dynamic form of cell death, which, when impeded, promises substantial cytoprotection.

14 November 2016 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
VKValerian E. Kagan
Valerian E. Kagan
GMGaowei Mao
Gaowei Mao
FQFeng Qu
Feng Qu
JAJose Pedro Friedmann Angeli
Jose Pedro Friedmann Angeli
SDSebastian Doll
Sebastian Doll
HBHülya Bayır
Hülya Bayır

14 August 2005 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
VKValerian E. Kagan
Valerian E. Kagan
VTVladimir A Tyurin
Vladimir A Tyurin
JJJianfei Jiang
Jianfei Jiang
YTYulia Y Tyurina
Yulia Y Tyurina
VRVladimir B Ritov
Vladimir B Ritov
GBGregory G Borisenko
Gregory G Borisenko

15 September 2013 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
CCCharleen T. Chu
Charleen T. Chu
JJJing Ji
Jing Ji
RDRuben Dagda
Ruben Dagda
JJJian Fei Jiang
Jian Fei Jiang
YTYulia Y. Tyurina
Yulia Y. Tyurina
VKValerian E. Kagan
Valerian E. Kagan
Recognition of injured mitochondria for degradation by macroautophagy is essential for cellular health, but the mechanisms remain poorly understood. Cardiolipin is an inner mitochondrial membrane phospholipid. We found that rotenone, staurosporine, 6-hydroxydopamine and other pro-mitophagy stimuli caused externalization of cardiolipin to the mitochondrial surface in primary cortical neurons and SH-SY5Y cells. RNAi knockdown of cardiolipin synthase or of phospholipid scramblase-3, which transports cardiolipin to the outer mitochondrial membrane, decreased the delivery of mitochondria to autophagosomes. Furthermore, we found that the autophagy protein microtubule-associated-protein-1 light chain 3 (LC3), which mediates both autophagosome formation and cargo recognition, contains cardiolipin-binding sites important for the engulfment of mitochondria by the autophagic system. Mutation of LC3 residues predicted as cardiolipin-interaction sites by computational modelling inhibited its participation in mitophagy. These data indicate that redistribution of cardiolipin serves as an ‘eat-me’ signal for the elimination of damaged mitochondria from neuronal cells.

1 October 2017 in Cell
Verified
Journal Article
Closed access
SWSally E. Wenzel
Sally E. Wenzel
YTYulia Y. Tyurina
Yulia Y. Tyurina
JZJinming Zhao
Jinming Zhao
CCClaudette M. St. Croix
Claudette M. St. Croix
HDHaider H. Dar
Haider H. Dar
VKValerian E. Kagan
Valerian E. Kagan

11 July 2010 in Nature Medicine
Verified
Journal Article
Open access
PDF file
DHDonna L Herber
Donna L Herber
WCWei Cao
Wei Cao
YNYulia Nefedova
Yulia Nefedova
SNSergey V Novitskiy
Sergey V Novitskiy
SNSrinivas Nagaraj
Srinivas Nagaraj
DGDmitry Gabrilovich
Dmitry Gabrilovich
Dendritic cells in individuals with cancer and in mouse tumor models show an increase in triacylglycerides that seems to impair their antigen-processing capability and could thus contribute to tumor immune tolerance. This aberrant lipid load results from tumor-induced elevation of the scavenger receptor Msr1 on dendritic cells, and it can be targeted therapeutically to improve the efficiency of anticancer vaccines. Dendritic cells (DCs), a type of professional antigen-presenting cells, are responsible for initiation and maintenance of immune responses. Here we report that a substantial proportion of DCs in tumor-bearing mice and people with cancer have high amounts of triglycerides as compared with DCs from tumor-free mice and healthy individuals. In our studies, lipid accumulation in DCs was caused by increased uptake of extracellular lipids due to upregulation of scavenger receptor A. DCs with high lipid content were not able to effectively stimulate allogeneic T cells or present tumor-associated antigens. DCs with high and normal lipid levels did not differ in expression of major histocompatibility complex and co-stimulatory molecules. However, lipid-laden DCs had a reduced capacity to process antigens. Pharmacological normalization of lipid abundance in DCs with an inhibitor of acetyl-CoA carboxylase restored the functional activity of DCs and substantially enhanced the effects of cancer vaccines. These findings suggest that immune responses in cancer can be improved by manipulating the lipid levels in DCs.